NERX Neorx (MM)

SEATTLE, Oct. 11 /PRNewswire-FirstCall/ -- NeoRx Corporation (NASDAQ:NERX), a cancer therapeutics development company, today announced that Jerry McMahon, Ph.D., chairman and CEO of NeoRx, will present at BIO InvestorForum 2005 on Wednesday, October 19, at 11:40 a.m. at The Palace Hotel in San Francisco. A live audio webcast will be available from the NeoRx web site (http://www.neorx.com/) under the "Investors" section. A replay of the presentation will be available for 10 days. About NeoRx NeoRx is a cancer therapeutics development company. The Company currently is focusing its development efforts on picoplatin (NX 473), a next-generation platinum therapy. A Phase II trial of picoplatin is currently underway for patients with small cell lung cancer. The Company also plans to undertake a Phase I/II trial of picoplatin in colorectal cancer. NeoRx also is collaborating with the Scripps Florida research institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors for the treatment of cancer. For more information, visit http://www.neorx.com/. DATASOURCE: NeoRx Corporation CONTACT: Julie Rathbun, Corporate Communications of NeoRx Corporation, +1-206-286-2517, or Web site: http://www.neorx.com/

Copyright